Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marina Bykova

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Human Molecular Genetics|August 26, 2022
Quantitative trait locus (xQTL) approaches identify risk genes and drug targets from human non-coding genomesMarina Bykova, Yuan Hou, Charis Eng, et al.
European Journal of Dentistry|August 11, 2020
Study of the Clinical Efficiency of an Interdisciplinary Approach to the Treatment of Orofacial Pain and Temporomandibular Joint Disorders in Patients with Complete or Partial EdentulismFatima Dzalaeva, Sergey Chikunov, Marina Bykova, et al.
International Journal of Environmental Research and Public Health|February 8, 2020
Comparative Analysis of the Reproduction Accuracy of Main Methods for Finding the Mandible Position in the Centric Relation Using Digital Research Method. Comparison between Analog-to-Digital and Digital Methods: A Preliminary ReportAndrey Stafeev, Aleksandr Ryakhovsky, Pavel Petrov, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
Drug DevelopmentMarina Bykova, Reina Tonegawa Kuji, Ehud Karavani, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|February 13, 2026
Network-based prediction and real-world patient data observation identify doxycycline as a repurposable drug in Alzheimer's diseaseMarina Bykova, Ehud Karavani, Michael Danziger, et al.
Alzheimer'S & Dementia (New York, N. Y.)|December 31, 2025
Critical evaluation of real-world evidence of repurposable medicines in the Alzheimer's disease drug development pipeline using a target trial emulationReina Tonegawa-Kuji, Ehud Karavani, Michael Danziger, et al.
Cell Reports|April 23, 2024
Systematic characterization of multi-omics landscape between gut microbial metabolites and GPCRome in Alzheimer's diseaseYunguang Qiu, Yuan Hou, Dhruv Gohel, et al.
Cell Reports. Medicine|September 6, 2024
Acutely blocking excessive mitochondrial fission prevents chronic neurodegeneration after traumatic brain injuryPreethy S Sridharan, Yeojung Koh, Emiko Miller, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Human Molecular Genetics|August 26, 2022
Quantitative trait locus (xQTL) approaches identify risk genes and drug targets from human non-coding genomesMarina Bykova, Yuan Hou, Charis Eng, et al.
European Journal of Dentistry|August 11, 2020
Study of the Clinical Efficiency of an Interdisciplinary Approach to the Treatment of Orofacial Pain and Temporomandibular Joint Disorders in Patients with Complete or Partial EdentulismFatima Dzalaeva, Sergey Chikunov, Marina Bykova, et al.
International Journal of Environmental Research and Public Health|February 8, 2020
Comparative Analysis of the Reproduction Accuracy of Main Methods for Finding the Mandible Position in the Centric Relation Using Digital Research Method. Comparison between Analog-to-Digital and Digital Methods: A Preliminary ReportAndrey Stafeev, Aleksandr Ryakhovsky, Pavel Petrov, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
Drug DevelopmentMarina Bykova, Reina Tonegawa Kuji, Ehud Karavani, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|February 13, 2026
Network-based prediction and real-world patient data observation identify doxycycline as a repurposable drug in Alzheimer's diseaseMarina Bykova, Ehud Karavani, Michael Danziger, et al.
Alzheimer'S & Dementia (New York, N. Y.)|December 31, 2025
Critical evaluation of real-world evidence of repurposable medicines in the Alzheimer's disease drug development pipeline using a target trial emulationReina Tonegawa-Kuji, Ehud Karavani, Michael Danziger, et al.
Cell Reports|April 23, 2024
Systematic characterization of multi-omics landscape between gut microbial metabolites and GPCRome in Alzheimer's diseaseYunguang Qiu, Yuan Hou, Dhruv Gohel, et al.
Cell Reports. Medicine|September 6, 2024
Acutely blocking excessive mitochondrial fission prevents chronic neurodegeneration after traumatic brain injuryPreethy S Sridharan, Yeojung Koh, Emiko Miller, et al.
Pageof 1